RxDoctor Payments Data

Girish Nadkarni, MD

Nephrology · New York, NYNPI 1407160138

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $279,483 of the $280,713 with a category attached, or 99.6%. Renalytix AI, Inc. accounts for 89.2% of it on its own, with 5 other manufacturers making up the rest. Among nephrology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$280,713in general payments, 2019–2025

Across 45 payments — averaging $6238.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Renalytix AI, Inc.$250K
  • GSK$10K
  • Vertex$9K
  • Daiichi Sankyo Company LTD$5K
  • Siemens Medical Solutions USA, Inc.$5K
  • AstraZeneca$2K
$696,971in research payments, 2019–2025

Across 2 payments — averaging $348,485 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Vertex$697K

What the payments were for

  • Consulting fees$279,483100%
  • Travel & lodging$1,1160%
  • Food & beverage$1150%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$280,713 in reported general payments places this provider in the 95th percentile of 935 nephrology providers in New York.

See all nephrology providers in New York

Medicare billing

Part B allowed, 2024
$1,651
Medicare patients
12
Services billed
16

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nephrology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →